What are the odds for a drug entering trials?
New to this industry?Start with its one-minute summary: Pharma, biotech and medtech
Bar chart: Chance of moving to the next phase, all drugs, 2011 to 2020. Values in percent. Phase I to Phase II: 52; Phase II to Phase III: 28.9; Phase III to filing for approval: 57.8; Filing to approval: 90.6.
Source: BIO, Informa Pharma Intelligence and QLS Advisors, Clinical Development Success Rates 2011 to 2020. Rates differ a lot by disease area.
The prompt
Using the phase success rates in the chart above, what is the chance that a drug entering Phase I is approved, and the chance for a drug entering Phase II?
Practice with a partner
1. Send the interviewer link to a friend. They read the case aloud and hold the answers.
2. You open the candidate view: you see only the prompt, a timer and a notes box.
3. Speak the case out loud. Your partner shares data when you ask, then scores you with the rubric.
Interviewer view
For the person running the case
Candidate view
For the person answering the case
Clarifying questions, with the interviewer's answers
My notes on this case
0 of 5,000 characters. Saves automatically.